← Leaderboards
Coy D Heldermon
University Of Florida
$4,153,336
Attributed
$4,982,234
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2010–25$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,982,234 · 3
By mechanism
R01$2,593,602 · 1
UG3$1,657,797 · 1
K08$730,835 · 1
Top collaborators
- Barry J. Byrne3 shared
Most similar at University Of Florida
Same institution · by research overlap
- Barry J. Byrne$9,633,932
- Emily K. Moser$1,407,466
Others in their field
Top investigators on “Lysosomal Storage Diseases”
- John H Wolfe · Children'S Hospital Of Philadelphia$28,073,185
- Ronald G Crystal · Weill Medical College Of Cornell Univ$16,870,313
- Stuart A Kornfeld · Washington University$16,342,633
- Patricia I Dickson · Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center$9,370,497
- Nancy M. Dahms · Medical College Of Wisconsin$9,170,286
- Sean Ekins · Genego, Inc.$9,102,826
Research focus
Lysosomal Storage DiseasesMouse ModelEnzymesGene TherapyAffectMucopolysaccharidosis ViiCellsBurden Of IllnessChildVectorCapsidCodon NucleotidesNerve DegenerationNonhuman PrimateViralHearingHeparitin SulfateProteinsCessation Of LifeBiodistributionBrainProgramsSerotypingMucopolysaccharidosis Iii
Grant awards (13)
Procession to IND of a capsid mutated AAV8 codon optimized NAGLU vector for treatment of Sanfilippo Syndrome type B (Supplement)$538,939
UG3 · FY2025 · NS · contact PI
Procession to IND of a capsid mutated AAV8 codon optimized NAGLU vector for treatment of Sanfilippo Syndrome type B$535,428
UG3 · FY2025 · NS · contact PI
Procession to IND of a capsid mutated AAV8 codon optimized NAGLU vector for treatment of Sanfilippo Syndrome type B$583,430
UG3 · FY2024 · NS · contact PI
Optimizing AAV Vectors for Central Nervous System transduction$477,909
R01 · FY2021 · NS · contact PI
Optimizing AAV Vectors for Central Nervous System transduction$526,679
R01 · FY2020 · NS · contact PI
Optimizing AAV Vectors for Central Nervous System transduction$501,617
R01 · FY2019 · NS · contact PI
Optimizing AAV Vectors for Central Nervous System transduction$463,361
R01 · FY2018 · NS · contact PI
Optimizing AAV Vectors for Central Nervous System transduction$624,036
R01 · FY2017 · NS · contact PI
Transplacental stem cell transplantation and evaluation of therapeutic effect$146,167
K08 · FY2014 · DK · contact PI
Transplacental stem cell transplantation and evaluation of therapeutic effect$146,167
K08 · FY2013 · DK · contact PI
Transplacental stem cell transplantation and evaluation of therapeutic effect$146,167
K08 · FY2012 · DK · contact PI
Transplacental stem cell transplantation and evaluation of therapeutic effect$146,167
K08 · FY2011 · DK · contact PI
Transplacental stem cell transplantation and evaluation of therapeutic effect$146,167
K08 · FY2010 · DK · contact PI